Clinical Medicine Reviews in Therapeutics

Bipolar Disorder in 10–17 Year Old Patients: Treatment Options and Cautions

Submit a Paper

Clinical Medicine Reviews in Therapeutics 2011:3


Published on 28 Jun 2011

DOI: 10.4137/CMRT.S3084

Further metadata provided in PDF

Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics


In recent years, bipolar disorder (BD) has been diagnosed with increasing frequency in the pediatric population. BD requires a multimodal treatment plan to address complex symptoms and the associated comorbidities. Pharmacological intervention assists the core symptoms of the illness and psychotherapeutic intervention may be beneficial as an adjunctive treatment. Controlled studies corroborate the comparable short-term efficacy of several second generation antipsychotics and mood stabilizers for treating mania, but major dissimilarities exist with respect to the kind and severity of side effects. The selected treatment option is determined by the tolerance and safety. In addition, data suggests that youth may be more vulnerable to the adverse effects of psychotropic medications than adults. More clinical trials, that focus on risk-benefit ratios of these medications and that clarify assessment and management of their comorbidities are needed to find safer and more effective treatment options for long-term treatment.



BibTex citation   (BIBDESK, LATEX)

What Your Colleagues Say About Libertas Academica
I experienced rapid and fair peer review and fast article publication. The competent editorial and production staff at Libertas Academica were attentive to every detail and were great at communicating with us during the review and publication process. Thank you for your great service.
Dr Geetanjali Gupta (Department of Pathology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India)
More Testimonials

Quick Links

New article and journal news notification services